608 related articles for article (PubMed ID: 10498396)
1. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix.
Wu M; Gunning W; Ratnam M
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):775-82. PubMed ID: 10498396
[TBL] [Abstract][Full Text] [Related]
2. Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies.
Figini M; Ferri R; Mezzanzanica D; Bagnoli M; Luison E; Miotti S; Canevari S
Gene Ther; 2003 Jun; 10(12):1018-25. PubMed ID: 12776159
[TBL] [Abstract][Full Text] [Related]
3. Haymaker gene expression in malignant and normal gynecologic tissues.
Borowsky ME; Das B; Axiotis CA; Malka ES; Abulafia O; Norin AJ
J Histochem Cytochem; 2006 Jul; 54(7):753-61. PubMed ID: 16495475
[TBL] [Abstract][Full Text] [Related]
4. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
5. Histologic type, organ of origin, and Wnt pathway status: effect on gene expression in ovarian and uterine carcinomas.
Shedden KA; Kshirsagar MP; Schwartz DR; Wu R; Yu H; Misek DE; Hanash S; Katabuchi H; Ellenson LH; Fearon ER; Cho KR
Clin Cancer Res; 2005 Mar; 11(6):2123-31. PubMed ID: 15788657
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric method for determining folate receptor expression on ovarian carcinoma cells.
Forster MD; Ormerod MG; Agarwal R; Kaye SB; Jackman AL
Cytometry A; 2007 Nov; 71(11):945-50. PubMed ID: 17712798
[TBL] [Abstract][Full Text] [Related]
7. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
[TBL] [Abstract][Full Text] [Related]
8. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization.
Ko J; Lee YH; Hwang SY; Lee YS; Shin SM; Hwang JH; Kim J; Kim YW; Jang SW; Ryoo ZY; Kim IK; Namkoong SE; Kim JW
Oncogene; 2003 Jul; 22(30):4679-89. PubMed ID: 12879013
[TBL] [Abstract][Full Text] [Related]
9. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
[TBL] [Abstract][Full Text] [Related]
10. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
Farley J; Gray K; Nycum L; Prentice M; Birrer MJ; Jakowlew SB
Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789
[TBL] [Abstract][Full Text] [Related]
11. Expression of midkine and pleiotropin in ovarian tumors.
Nakanishi T; Kadomatsu K; Okamoto T; Tomoda Y; Muramatsu T
Obstet Gynecol; 1997 Aug; 90(2):285-90. PubMed ID: 9241309
[TBL] [Abstract][Full Text] [Related]
12. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
Onuma K; Dabbs DJ; Bhargava R
Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
[TBL] [Abstract][Full Text] [Related]
13. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
[TBL] [Abstract][Full Text] [Related]
14. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
15. Differentiation margins of ovarian tumor pathology: first incidences of epithelial ovarian tumors monitored by marker antibodies.
van Niekerk CC; Vooijs P; Casparie-van Velsen IJ; Poels LG
Cancer Detect Prev; 1997; 21(3):247-57. PubMed ID: 9167042
[TBL] [Abstract][Full Text] [Related]
16. Distribution of histo-blood group antigens in cervical and uterine endometrium.
Stubbe Teglbjaerg C; Ravn V; Mandel U; Dabelsteen E
APMIS Suppl; 1991; 23():100-6. PubMed ID: 1883633
[TBL] [Abstract][Full Text] [Related]
17. Maternal folate deficiency results in selective upregulation of folate receptors and heterogeneous nuclear ribonucleoprotein-E1 associated with multiple subtle aberrations in fetal tissues.
Xiao S; Hansen DK; Horsley ET; Tang YS; Khan RA; Stabler SP; Jayaram HN; Antony AC
Birth Defects Res A Clin Mol Teratol; 2005 Jan; 73(1):6-28. PubMed ID: 15641086
[TBL] [Abstract][Full Text] [Related]
18. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
19. Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts.
Woo MM; Gilks CB; Verhage HG; Longacre TA; Leung PC; Auersperg N
Gynecol Oncol; 2004 May; 93(2):315-9. PubMed ID: 15099939
[TBL] [Abstract][Full Text] [Related]
20. High-affinity folate receptor in human ovary, serous ovarian adenocarcinoma, and ascites: radioligand binding mechanism, molecular size, ionic properties, hydrophobic domain, and immunoreactivity.
Holm J; Hansen SI; Høier-Madsen M; Birn H; Helkjaer PE
Arch Biochem Biophys; 1999 Jun; 366(2):183-91. PubMed ID: 10356282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
